[HTML][HTML] Roles of mitogen-activated protein kinases in osteoclast biology

K Lee, I Seo, MH Choi, D Jeong - International journal of molecular …, 2018 - mdpi.com
Bone undergoes continuous remodeling, which is homeostatically regulated by concerted
communication between bone-forming osteoblasts and bone-degrading osteoclasts …

[HTML][HTML] Roles of cyclic AMP response element binding activation in the ERK1/2 and p38 MAPK signalling pathway in central nervous system, cardiovascular system …

Y Koga, H Tsurumaki, H Aoki-Saito, M Sato… - International journal of …, 2019 - mdpi.com
There are many downstream targets of mitogen-activated protein kinase (MAPK) signalling
that are involved in neuronal development, cellular differentiation, cell migration, cancer …

Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF‐κB pathway

Y Li, Q Zhuang, L Tao, K Zheng, S Chen… - Cell …, 2022 - Wiley Online Library
Objectives The main target of current drugs for alleviating bone loss is osteoclasts. However,
the long‐term application of such drugs will also cause side effects. Therefore, it is of great …

[HTML][HTML] Alendronate loaded graphene oxide functionalized collagen sponge for the dual effects of osteogenesis and anti-osteoclastogenesis in osteoporotic rats

Y Zeng, M Zhou, L Chen, H Fang, S Liu, C Zhou, J Sun… - Bioactive materials, 2020 - Elsevier
Graphene Oxide (GO)-related hydrogels have been extensively studied in hard tissue repair,
because GO can not only enhance the mechanical properties of polymers but also promote …

Increased trabecular bone and improved biomechanics in an osteocalcin-null rat model created by CRISPR/Cas9 technology

LJ Lambert, AK Challa, A Niu, L Zhou… - Disease models & …, 2016 - journals.biologists.com
Osteocalcin, also known as bone γ-carboxyglutamate protein (Bglap), is expressed by
osteoblasts and is commonly used as a clinical marker of bone turnover. A mouse model of …

[HTML][HTML] Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma

ME Issa, FS Takhsha, CS Chirumamilla… - Clinical …, 2017 - Springer
Multiple myeloma (MM) is a hematological malignancy, which remains incurable because
most patients eventually relapse or become refractory to current treatments. Due to …

[HTML][HTML] Notopterol Attenuates Estrogen Deficiency-Induced Osteoporosis via Repressing RANKL Signaling and Reactive Oxygen Species

D Chen, Q Wang, Y Li, P Sun, V Kuek, J Yuan… - Frontiers in …, 2021 - frontiersin.org
Integrity of the skeleton is sustained through the balanced activities of osteoblasts and
osteoclasts in bone remodeling unit. The balance can be disrupted by excessive osteoclasts …

Molecular signaling in bone cells: Regulation of cell differentiation and survival

LI Plotkin, A Bruzzaniti - Advances in protein chemistry and structural …, 2019 - Elsevier
The achievement of proper bone mass and architecture, and their maintenance throughout
life requires the concerted actions of osteoblasts, the bone forming cells, and osteoclasts …

[HTML][HTML] Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways

XL Huang, LY Huang, YT Cheng… - International …, 2019 - spandidos-publications.com
It is well known that extensive osteoclast formation plays a key role in osteoporosis in post‑
menopausal women and the elderly. The suppression of extensive osteoclastogenesis and …

Metal–Organic Framework‐Based Nanomaterials for Regulation of the Osteogenic Microenvironment

W Zheng, Z Meng, Z Zhu, X Wang, X Xu, Y Zhang… - Small, 2024 - Wiley Online Library
As the global population ages, bone diseases have become increasingly prevalent in
clinical settings. These conditions often involve detrimental factors such as infection …